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Effect direction (evidence to indicate improvement, deterioration, or no
change in an outcome) can be used as a standardized metric which enables the
synthesis of diverse effect measures in systematic reviews. The effect direction
(ED) plot was developed to support the synthesis and visualization of effect
direction data. Methods for the ED plot require updating in light of new
Cochrane guidance on alternative synthesis methods. To update the ED plot,
statistical significance was removed from the algorithm for within-study syn-
thesis and use of a sign test was considered to examine whether patterns of ED
across studies could be due to chance alone. The revised methods were applied
to an existing Cochrane review of the health impacts of housing improve-
ments. The revised ED plot provides a method of data visualization in synthe-
sis without meta-analysis that incorporates information about study
characteristics and study quality, using ED as a common metric, without rely-
ing on statistical significance to combine outcomes of single studies. The
results of sign tests, when appropriate, suggest caution in over-interpreting
apparent patterns in effect direction, especially when the number of included
studies is small. The revised ED plot meets the need for alternative methods of
synthesis and data visualization when meta-analysis is not possible, enabling a
transparent link between the data and conclusions of a systematic review. ED
plots may be particularly useful in reviews that incorporate nonrandomized
studies, complex systems approaches, and diverse sources of evidence, due to
the variety of study designs and outcomes in such reviews.
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1 | INTRODUCTION
This article describes a revised method for the effect
direction plot1 in light of recent Cochrane guidance.
Effect direction (evidence to indicate improvement, dete-
rioration, or no change in an outcome) can be used as a
standardized metric to encompass a wide variety of data
in systematic reviews in which standardized effect sizes
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cannot be obtained for all included studies. Such situa-
tions, in which some form of “narrative synthesis” is con-
ducted rather than meta-analysis, are common2,3;
approximately half of Cochrane reviews include a narra-
tive approach to synthesis for some or all outcomes.4
The effect direction plot was devised as an approach to
support synthesis where effect direction is used as the com-
mon metric, principally by providing a way of visualizing
the data and promoting transparent links between the data
and the narrative.1 In the 2013 Cochrane review of housing
improvements for health, for example, the effect direction
plot was implemented to combine and present findings on
four key health outcome domains for outcomes that were
conceptually similar but measured in disparate ways.5 In
each individual study, similar outcomes (eg, cough fre-
quency, cough at night, wheeze, lower respiratory symp-
toms) are combined into a single outcome domain (in this
example, “respiratory health”). An overall direction of
effect for the outcome domain for each study is calculated
using an algorithm based on the proportion of outcomes
within an outcome domain that reported statistically signif-
icant effects in a given direction. The effect direction for
the outcome domain for each study is then visually repre-
sented as an upwards, downwards, or bidirectional arrow.
The shading of the arrow indicates whether or not the
majority of results for the outcome were statistically signifi-
cant. The size of the arrow represents the sample size. In
the housing improvement review, use of the effect direction
plot enabled a 10 000 word review of complex interven-
tions to be summarized and visually displayed in a graphic
tabulation on a single page.1
The 2019 Cochrane Handbook provides a new chapter
on synthesizing and presenting findings using methods
other than meta-analysis.6 This chapter notes several accept-
able alternatives to meta-analysis, including vote counting
based on effect direction. However, it also notes that vote
counting by statistical significance, and vote counting based
on subjective rules, are unacceptable. The chapter suggests
that a sign test can be applied in the synthesis of effect direc-
tion to test whether there is any evidence of an effect, or if
the true proportion of effects favoring the intervention is 0.5,
that is, no better than chance.
The aim of this study was to apply the new Handbook
guidance and update the effect direction plot, using as an
example a re-analysis of the results for the intervention
of warmth and energy efficiency improvements included
in the Cochrane housing improvement review.
2 | METHODS
The methods of producing effect direction plots have
been previously reported.1 To update those methods,
statistical significance was removed from the visual pre-
sentation of the effect direction and from the algorithm
for within-study synthesis of related outcomes. The use of
a sign test was explored to provide a statistical test to sup-
port the synthesis of effect direction across studies for
any single outcome domain. Studies and data from the
Cochrane housing improvement review were re-analyzed
by applying the revised algorithm and conducting sign
tests for each outcome.
The effect direction plot was then prepared as per the
methods originally reported, but with the following
changes. Study quality was represented by shading each
study row according to its critical appraisal result,
adapting the familiar traffic light system by using green
shading for high-quality and amber for moderate-quality
studies. To support implementation, a github repository
for the effect direction plot was created at https://github.
com/michelehb/effdir/. The first entry in this repository,
an Excel spreadsheet (see Supporting Information in
Appendix S1), provides a template for entering data for
the plot, including drop-down lists with the necessary
characters for the effect direction arrows, conditional for-
matting to automatically color the rows according to each
study's overall risk of bias, and instructions on using and
troubleshooting the template. Box 1 describes the
updated method step by step.
The sign test is a nonparametric test that uses a
binary measure of either a positive or a negative effect to
test whether there is sufficient evidence to reject the null
hypothesis of an equal number of positive and negative
results.7 The P-value from a sign test represents the prob-
ability of observing the given number of positive and neg-
ative results if the null hypothesis were true. To perform
the test, we counted the number of positive and negative
effect direction arrows for each outcome domain. Studies
with inconsistent effect direction for a given outcome
domain were excluded from the count as they could not
be said to represent either a positive or a negative effect
direction. We used GraphPad (https://www.graphpad.
com/quickcalcs/binomial1/) to calculate the two-tailed P-
value for each outcome domain.
3 | RESULTS
Figure 1 shows the result of applying the updated
methods for the effect direction plot to the outcomes of
housing condition, general health, and respiratory health
reported in the Cochrane review. For housing condition,
9 of the 10 studies reported a positive effect direction,
with one study reporting conflicting or unclear effects.
The P-value for the sign test for this outcome domain is
.0039. For general health, 5 studies reported a positive
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effect direction, 1 negative, and 1 conflicting/unclear
(P value for sign test .2188). For respiratory health, 5 stud-
ies reported a positive effect direction, 1 negative, and
4 conflicting/unclear (P value for sign test .2188). Studies
with conflicting or unclear effect direction could not be
included in the sign test.
Box 1 Steps to produce an effect direction plot
1. Effect direction synthesis
Within each study:
1a. Group related outcomes into outcome domains
1b. Count positive and negative effect estimates within each domain
1c. Determine overall effect direction for each domain using the following algorithm:
Where multiple outcomes within a study all report effect in same direction, report that effect direction
for the domain
Where direction of effect varies across multiple outcomes within a study:
Report direction of effect where 70% (ie, a clear majority) of outcomes report similar direction
If <70% of outcomes report consistent direction of effect then report no clear effect/conflicting find-
ings ◀▶
2. Preparation of effect direction plot
2a. Complete the template (Appendix S1) with study characteristics and outcome domains to be
represented.
2b. Within each study-domain cell, insert arrows to indicate overall effect direction and relative sample size
for that study and domain:
Upward arrow ▲ = positive health impact, downward arrow ▼ = negative health impact, sideways
arrow ◀▶ = no change/mixed effects/conflicting findings
Set arrow size (small, medium, large) to reflect relative sample size, for example, final sample size (indi-
viduals) in intervention group ▲ > 300; ▲ 50-300; ▲ < 50
If >1 outcome is represented in a study-domain cell, a subscript number can be placed beside the effect
direction arrow to indicate the number of outcomes from the study represented by the arrow
2c. Denote study quality by row color shading: green = high quality/low risk of bias; yellow = moderate/some
concerns; red = low quality/high risk of bias.
FIGURE 1 Effect direction plot
summarizing direction of health impacts
from studies of housing interventions to
improve warmth and energy efficiency
[Colour figure can be viewed at
wileyonlinelibrary.com]
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4 | DISCUSSION
The updated effect direction plot provides a method of syn-
thesis and visualization of effect direction that removes the
reliance on statistical significance to combine multiple simi-
lar outcomes from single studies, in line with updated meth-
odological guidance from Cochrane. When meta-analysis is
not possible, alternative methods are needed that support
synthesis and data visualization for diverse outcomes while
ensuring a transparent link between the data and conclu-
sions of a systematic review.8 The revised effect direction plot
meets this need and has the potential to be implemented in
the majority of public health systematic reviews.
The sign test may provide additional information and
aid transparency in the interpretation of the overall pat-
tern of effect direction; however, introducing a sign test
to effect direction synthesis raises several issues. First,
the power of the sign test may be limited if the review
contains a small number of studies, and further limited
by the need to discount studies with an unclear effect
direction, reducing the number of studies included in the
test. Consider a hypothetical example in which a synthe-
sis includes 20 studies, of which 11 have conflicting find-
ings, 8 positive effect direction results, and 1 negative.
The sign test will be based on only 9/20 included studies
and will arguably misrepresent the synthesis. The effect
direction plot has the strength of being able to represent
all studies included in a review, but the sign test
does not.
Second, well-recognized caveats about the limitations
of P-values and significance testing in judging associa-
tions and effects should be kept in mind when reporting
syntheses that use the revised effect direction plot.9,10
Statements that patterns of effect direction are or are not
“statistically significant” should be avoided in line with
recent advice.10 Instead, results of the sign test might best
be used to ensure that the “cognitive algebra”11 associ-
ated with vote counting remains mindful of uncertainty,
and modest in supporting claims regarding intervention
effectiveness.
Third, the sign test would only be appropriate if
underlying assumptions were met and were appropriately
powered. It has been argued that the sign test is inappro-
priate for synthesis of effect direction because the under-
lying assumption of a binomial distribution is not met
and because it will typically be underpowered in the syn-
theses where it is likely to be useful.12 Additionally, the
sign test should not be used in synthesis of effect direc-
tion if publication bias is suspected.
We plan to continue to develop this method of visual-
ization and further support its implementation. Future
development should consider how sensitive the algorithm
is to different methods of addressing within-study
multiplicity of outcomes,13 comparison with other
methods of visual display of nonstandardized effects,14,15
and debates about how to represent and interpret uncer-
tainty.10,16 Effect direction as a type of standardized met-
ric merits methodological attention, given the proportion
of reviews in which meta-analysis cannot be undertaken
and the need for clear communication of the synthesis of
such reviews. Effect direction plots may be particularly
useful in reviews that incorporate non-randomized stud-
ies, complex systems approaches, and diverse sources of
evidence, due to the variety of study designs and out-
comes in such reviews.
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